NCT00229450View on ClinicalTrials.gov

Estrogen and Perimenopausal Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 30, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2004

Conditions
Depressive Disorder, MajorMenopause
Interventions
DRUG

Estrogen

0.625 mg/day of conjugated Estrogen

Trial Locations (1)

90024

UCLA Neuropsychiatric Institute & Hospital, Los Angeles

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

University of California, Los Angeles

OTHER

NCT00229450 - Estrogen and Perimenopausal Depression | Biotech Hunter | Biotech Hunter